Stealth BioTherapeutics, Inc., is a clinical stage, biopharmaceutical company developing novel mitochondrial targeted therapies for diseases with clear unmet medical needs including cardiovascular, renal and metabolic diseases. The company’s first clinical candidate, Bendaviaâ„¢, targets the mitochondria to treat cardio-renal and microvascular impairments.
OptiGen, LLC, provides DNA-based diagnoses and information about inherited diseases of dogs. OptiGen was acquired by Mars Petcare in 2018.
GeneWeave Biosciences, Inc., is a medical diagnostics company focused on infectious diseases. GeneWeave was acquired by Roche Holding AG in 2015.
Acuamark Diagnostics is developing novel diagnostic tests to enable low-cost and accurate early detection of colorectal cancer directly from the blood, by isolating and identifying multiple cancer markers. Thus, allowing for improved sensitivity, specificity, and scalability.